 with
dextran 40.144 Recent work suggested that dextran may
exert a combined therapeutic effect by enhancing
endogenous ﬁbrinolysis as well as reducing platelet
adhesion to von Willebrand factor and platelet activation
by thrombin.145
Although these observations make a compelling case
for the efﬁcacy of dextran use among patients undergoing CEA, objective clinical beneﬁt has not been
